International Business Machines (IBM) has secured a landmark $1 billion federal award from the U.S. Department of Commerce under the CHIPS and Science Act. The deal finalized non-dilutive funding to accelerate quantum wafer manufacturing at Anderon, a dedicated quantum foundry company spun out by IBM.
At the time of writing, IBM shares are down about 17% versus the start of this year.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
www.barchart.comWhat the Anderon News Means for IBM Stock
This $1 billion federal award validates IBM’s pivot toward high-margin, deep-tech infrastructure.
Combined with its matching $1 billion internal capital commitment, the funds will scale Anderon’s 300-millimeter quantum wafer foundry in Albany, New York.
As the premier domestic pure-play quantum foundry, Anderon positions IBM right at the center of the quantum hardware supply chain, providing “specialized components” to third-party quantum vendors.
The finalized contract is bullish for IBM stock as it could transform the firm’s speculative quantum research efforts into an immediate commercial moat with direct government support.
Note that a healthy 2.82% dividend yield makes IBM even more attractive as a long-term holding.
Should You Invest in IBM Shares Today?
IBM shares remain attractive because of the company’s ongoing transformation into a high-margin enterprise hybrid cloud and AI powerhouse.
This was evidenced in its latest quarterly print, which showed the Software segment’s annual recurring revenue (ARR) exceeding $24 billion on double-digit expansion in Red Hat and strong enterprise adoption of its data and AI platforms.
Plus, IBM is currently trading at a forward price-to-earnings (P/E) multiple of about 20x, which makes it rather attractive for an artificial intelligence beneficiary.
All in all, at current levels, IBM provides investors with a dependable blend of recurring enterprise cash flows and exposure to next-gen tech.
IBM Remains Buy-Rated Among Wall Street Firms
Investors should also note that Wall Street analysts view the year-to-date pullback in IBM stock as overdone, and recommend betting on the tech giant’s longer-term recovery.
According to Barchart, the consensus rating on IBM sits at “Moderate Buy,” with price targets as high as $365 indicating potential for another 45% rally from here.
www.barchart.com On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
Investors Don’t Have 9 Lives, So Stop Chasing Dead-Count Bounces in Hot Stocks Like Broadcom NVO Stock Alert: What to Know as Novo Partners With Anthropic on Drug Discovery A $10 Trillion Reason Why SpaceX Stock Is Up Today Why It’s Time to Load Up on Nvidia Stock